Alle Bell- en Gongceremonies

Sonans admitted to trading

Sonans admitted to trading on Euronext Growth Oslo 17 February 2021.

Technip Energies lists on Euronext Paris

Arnaud Pieton , Chief Executive Officer of Technip Energies , opens the trading day in Paris.

Created from the spin-off from TechnipFMC plc group in 2021, Technip Energies N.V. is an Engineering and Technology company specialized in providing projects, technologies, products and services on energy infrastructure both onshore and offshore (LNG, downstream, sustainable chemistry, hydrogen, CO2 management and marine infrastructure).

Pryme admitted to trading

Pryme admitted to trading on Euronext Growth Oslo 16 February 2021.

Huddly admitted to trading

Huddly admitted to trading on Euronext Growth Oslo 16 February 2021.

Rize ETF – ETFs Listings

Rize ETF viert dat zij vandaag drie ETF’s noteren op Euronext. Jason Kennard, mede-oprichter van Rize ETF, luidde daarom op afstand de gong. Dit deed hij in het bijzijn van onder meer Thomas Weber, ETFs Manager Bedrijfsontwikkeling bij Euronext. De 3 genoteerde ETFs zijn Cybersecurity, Edtech en Sustainable food.

ESG Core Investments – SPAC Listing en eerste handelsdag

Hans Slootweg, Managing Director van ESG Core Investments, werd verwelkomd door Simone Huis in ’t Veld, CEO van Euronext Amsterdam. Van Roij luidde de gong naar aanleiding van de notering van ESG Core Investments, een Special Purpose Acquistion Company (SPAC) met een sterke focus op Environment, Social and Governance (ESG). Het is de eerste SPAC-listing op Euronext van dit jaar.

Beaconsmind lists on Euronext Access+ Paris

Max Weiland , CEO and Founder, of Beaconsmind , open the trading day in Paris.

Beaconsmind AG specializes in the development of location-based marketing software solutions for retailers. The group allows retailers to carry out marketing campaigns to increase customer loyalty, revenue and sales at the point of sale and in online.

Medesis Pharma lists on Euronext Growth Paris

Jean-Claude Maurel , CEO and Founder of Medesis Pharma, opens the trading day in Paris.

Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

The company's portfolio includes two candidates in the fields of neurodegenerative diseases (Alzheimer's disease and Huntington's disease), two candidates for antiviral treatments to respond to the health emergency towards the treatment of COVID-19 at different stages (one for hospitalized patients in acute respiratory distress, and another for early treatment in urban medicine), and 2 candidates to treat contaminated populations after a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).

UBS Asset Management – 20 jaar ETFs

UBS Asset Management vierde vandaag dat zij al twintig jaar ETFs aanbieden. Marcel Danen, Executive Director van UBS, luidde daarom op afstand de gong, in het bijzijn van onder meer Brieuc Louchard, verantwoordelijk voor ETFs binnen Euronext. Tien jaar geleden lanceerde het bedrijf haar eerste duurzame ETF en sinds vijf jaar zijn verschillende ETFs genoteerd aan de Amsterdamse beurs.

Hydrogen Refueling Solutions lists on Euronext Growth Paris

Hassen Rachedi , CEO and Founder, Philippe Bottu, General Manager, and Olivier Dhez, Business Development & Marketing Director of Hydrogen Refueling Solutions , open the trading day in Paris.

Hydrogen Refueling Solutions is specialized in the mass production of turnkey hydrogen refueling stations with large capacities (100 kg to 1 ton) for heavy vehicles (transport, buses, garbage trucks, etc.) and passenger vehicles.

At the end of 2020, the group has a production site located in France.

Cambi admitted to trading

Cambi admitted to trading on Euronext Growth Oslo 9 February 2021.

Pherecydes Pharma lists on Euronext Growth Paris

Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, opens the trading day in Paris.

Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

Okeanis Eco Tankers listed on Oslo Børs

Okeanis Eco Tankers listed on Oslo Børs 29 January 2021.

Kick-off TechShare Nederland 2020-2021

Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde de gong als aftrap van het TechShare Nederland 2020-2021 programma. TechShare is het opleidingsprogramma van Euronext voor Tech entrepreneurs. Het laat hen kennismaken met de mogelijkheden van de financiële kapitaalmarkten.

Wereldkankerdag

Op Wereldkankerdag wordt er meer dan anders gevraagd om aandacht te geven aan kankerpatiënten. Samen met Dick Plomp, ervaringsdeskundige namens de Nederlandse Federatie van Kankerpatiëntenorganisaties, luidde Euronext’s communicatiemanager Marianne Aalders vanochtend de gong.

Proximar Seafood admitted to trading

Proximar Seafood admitted to trading on Euronext Growth Oslo 3 February 2021.

Winnaar KVK Innovatie Top 100

Het bedrijf Somnox, bekend van hun slaaprobot, is de winnaar van de 15^e editie van de Kamer van Koophandel’s Innovatie Top 100. Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde vandaag ter gelegenheid hiervan de gong namens Somnox’ CEO Julian Jagtenberg.

Aker Horizons admitted to trading

Aker Horizons admitted to trading on Euronext Growth Oslo 1 February 2021.